PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
NCT07242586 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-12-10
Summary
Overview:
People with psychotic disorders frequently have a history of traumatic events such as neglect, bullying, or physical and sexual abuse. Many experience significant symptoms of post-traumatic stress, but trauma-focused treatment is rarely offered in standard psychiatric care. This pilot study investigates whether two established trauma therapies can be delivered safely and acceptably to young adults with psychotic disorders receiving care in the OPUS early-intervention program.
Objectives:
The main aim is to evaluate the feasibility and acceptability of two trauma-focused treatments-Prolonged Exposure (PE) and Eye Movement Desensitization and Reprocessing (EMDR)-in patients with psychotic disorders and post-traumatic stress symptoms. The study is not designed to test treatment efficacy but to determine whether a larger randomized controlled trial is practical.
Study Design:
This is a pilot and feasibility study. Twenty OPUS patients with a diagnosis within the schizophrenia spectrum and clinically relevant PTSD symptoms will be randomly assigned to either PE or EMDR. All participants continue their usual OPUS care while attending weekly trauma-focused therapy sessions.
Assessments:
At baseline and follow-up, participants complete clinical interviews and questionnaires assessing trauma symptoms, psychotic symptoms, functioning, well-being, recovery experiences, and possible negative effects. Instruments include the PCL-5, CAPS-5, Mini-TALE, PANSS-6, PSP, WHO-5, Brief INSPIRE-O, NEQ, and CSQ.
Primary Feasibility Outcomes:
Recruitment: At least 80% of the planned sample enrolled within 6 months.
Retention: At least 70% completing ≥12 therapy sessions.
Acceptability: Participant satisfaction measured with the Client Satisfaction Questionnaire (CSQ).
Eligibility:
Inclusion:
Age ≥18
Diagnosis within the schizophrenia spectrum (ICD-10: F20-F29)
PTSD symptom score \>31 on PCL-5
Current OPUS patient
Sufficient Danish language skills
Exclusion:
Substance use that prevents participation (e.g., attending sessions intoxicated)
Severe cognitive impairment
Recent changes in antipsychotic medication (within 1 month)
Risks and Safety:
Temporary increases in PTSD symptoms may occur when beginning trauma therapy; this pattern is well documented and typically followed by improvement. Previous studies show no higher risk of serious adverse events among patients with psychosis receiving trauma treatment compared with those who do not. Participants are closely monitored, and the study team works in continuous collaboration with OPUS clinicians. If a participant experiences significant clinical deterioration, the therapy can be paused or stopped, and supportive measures will be provided.
Potential Benefits:
Participants may experience a reduction in trauma-related symptoms and gain access to a treatment that is not otherwise routinely offered to patients with psychotic disorders. The study may help improve future care for this underserved population.
Funding:
The study is funded by the Nektar Foundation and conducted at the CORE Research Unit, Mental Health Services Copenhagen.
Conditions
- SCHIZOPHRENIA 1 (Disorder)
- Schizotypal Disorder
- Post Traumatic Stress Symptoms
Interventions
- BEHAVIORAL
-
Prolonged Exposure
Distinguishing Features - Prolonged Exposure (PE) Arm This intervention is distinguished by its exclusive reliance on systematic, therapist-guided exposure procedures grounded in emotional-processing theory. PE uses structured imaginal and in-vivo exposure to reduce avoidance and fear responses and does not employ bilateral stimulation, cognitive restructuring, or memory-processing elements characteristic of other trauma-focused approaches. The protocol follows a fixed sequence emphasizing habituation and extinction learning, making it operationally and mechanistically distinct from EMDR and from supportive or stabilization-oriented therapies used in similar clinical studies.
- BEHAVIORAL
-
EMDR
Distinguishing Features - EMDR Arm This intervention is distinguished by its use of the standardized eight-phase EMDR protocol, which combines brief exposure to trauma memories with bilateral sensory stimulation to facilitate adaptive information processing. EMDR does not require prolonged or repeated imaginal exposure, fear-hierarchy construction, or systematic in-vivo exposure, differentiating it from PE and other exposure-based trauma treatments. Its mechanism centers on accelerating memory reprocessing rather than habituation, and the protocol includes unique components such as cognition rating, desensitization with bilateral stimulation, installation, and body scan procedures.
Sponsors & Collaborators
-
Nikolai Albert
lead OTHER
Principal Investigators
-
Nikolai Albert · Mental Health Services in the Capital Region, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-02
- Primary Completion
- 2026-05-31
- Completion
- 2026-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms
NCT05619822 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Stabilizing Group Treatment of Complex Trauma: A Randomized Controlled Trial
NCT02450617 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Trauma Treatment in the Specialist Health Care Services
NCT06691347 ·Status: RECRUITING ·Phase: NA
-
Trauma-focused Group Music and Imagery With Traumatized Women
NCT03503526 ·Status: COMPLETED ·Phase: NA
-
Use of Electroconvulsive Therapy (ECT) in Chronic, Severe, Treatment Resistant Posttraumatic Stress Disorder
NCT00739856 ·Status: COMPLETED ·Phase: NA
-
Psychotherapy for Psychosis, Adverse Events, and Substance Misuse
NCT04546178 ·Status: COMPLETED ·Phase: NA
-
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
NCT06954025 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Psychotrauma Prevention Algorithm : Randomized, Controlled Pilot Study
NCT06366191 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A fMRI Study of the Treatment of Danish Veterans With PTSD With Prolonged Exposure Therapy
NCT02519296 ·Status: UNKNOWN ·Phase: NA
-
The Key to Integrated Trauma Treatment in Psychosis Trial
NCT06608706 ·Status: RECRUITING ·Phase: NA
-
PTSD Among Victims of Sexual Abuse and Changes in Structural and Functional Brain Connectivity
NCT01405495 ·Status: COMPLETED
-
The Effect of Dual Attention in an EMDR Intervention
NCT05600868 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)
NCT00635635 ·Status: COMPLETED ·Phase: NA
-
Blended Treatment för PTSD Feasibility Study
NCT04881643 ·Status: COMPLETED ·Phase: NA
-
Neurobehavioral Moderators of Post-traumatic Disease Trajectories
NCT03756545 ·Status: COMPLETED
-
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
NCT01492699 ·Status: COMPLETED ·Phase: NA
-
Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma
NCT01443182 ·Status: COMPLETED ·Phase: NA
-
Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial
NCT01713556 ·Status: COMPLETED ·Phase: PHASE2
-
Back Pain and PostTraumaticStressDisorder. A Randomized Clinical Trial
NCT02298764 ·Status: COMPLETED ·Phase: NA
-
Short Course Glucocorticoid Treatment for PTSD
NCT00204737 ·Status: COMPLETED ·Phase: PHASE4
-
fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating
NCT00288314 ·Status: COMPLETED
-
Patient-centered Modular CBT for CPTSD: A Randomised Controlled Pilot Study
NCT05259592 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Prolonged Exposure of PTSD in a Community Setting of PTSD Sufferers
NCT00521768 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD
NCT03449576 ·Status: COMPLETED ·Phase: NA
-
PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD
NCT06279598 ·Status: RECRUITING ·Phase: NA